All In Biotech

Drug Trial Radar · NCT00296855

Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease

Intra-individual Open-label Multicenter Comparison Study of Magnetic Resonance Angiography (MRA) With the Blood Pool Contrast Agent Vasovist® and a Conventional Extracellular Contrast Agent With Intra-arterial Digital Subtraction Angiography (i.a. DSA) in Patients With Peripheral Artery Disease

Last checked: Nov 20, 2026Latest source record: Apr 23, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

261

Actual

Start

Feb 2006

Primary completion

Not stated

Study completion Feb 2007

Sponsor

Lead sponsor
BayerBayer (BAYRY)
Sponsor type
Industry
First posted
Feb 27, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The particular aim of this study is the comparison of the diagnostic results of MRA images upon application of Vasovist (gadofosveset), a contrast agent not yet available on the market, with the MRA images upon application of a conventional extracellular contrast agent. A catheter angiography, which will be performed as a routine diagnostic procedure for vascular diseases, will serve as an evaluation standard.

Conditions

  • Peripheral Vascular Diseases

Interventions

  • Vasovist (BAY86-5283, MS-325)Drug

    All patients receive a single IV bolus injection of Vasovist at a dose of 0,03 mmol/kg BW at a flowrate of 0,5 mL/sec, followed by a saline flush of at least 30 mL

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Diagnostic potential of Vasovist enhanced MRATime frame: Imaging after baseline visit, before and after Vasovist injection

Locations

26 sites in 6 countries. Site status is shown where the registry gives one.

  • Site not named

    Buenos Aires, Buenos Aires, Argentina

  • Site not named

    Lornas de Zamora, Buenos Aires, Argentina

  • Site not named

    Buenos Aires, Buenos Aires F.D., Argentina

  • Site not named

    Buenos Aires, Buenos Aires F.D., Argentina

  • Site not named

    Sankt Pölten, Lower Austria, Austria

  • Site not named

    Vienna, State of Vienna, Austria

  • Site not named

    Vienna, State of Vienna, Austria

  • Site not named

    Graz, Styria, Austria

  • Site not named

    Curitiba, Paraná, Brazil

  • Site not named

    Rio de Janeiro, Rio de Janeiro, Brazil

  • Site not named

    São Paulo, São Paulo, Brazil

  • Site not named

    São Paulo, São Paulo, Brazil

  • Site not named

    Hamburg, Free and Hanseatic City of Hamburg, Germany

  • Site not named

    Frankfurt am Main, Hesse, Germany

  • Site not named

    Frankfurt am Main, Hesse, Germany

  • Site not named

    Bonn, North Rhine-Westphalia, Germany

  • Site not named

    Cologne, North Rhine-Westphalia, Germany

  • Site not named

    Essen, North Rhine-Westphalia, Germany

  • Site not named

    Münster, North Rhine-Westphalia, Germany

  • Site not named

    Mainz, Rhineland-Palatinate, Germany

  • Site not named

    Berlin, State of Berlin, Germany

  • Site not named

    Mexico D. F., Mexico

  • Site not named

    México D.F., Mexico

  • Site not named

    Monterrey, Nuevo León, Mexico

  • Site not named

    Baden, Switzerland

  • Site not named

    Basel, Basel, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.